text.skipToContent text.skipToNavigation
Pharma & Biotech

Transfection

7 Products found
  • 4D-Nucleofector<sup>TM</sup> Y Unit
    4D-NucleofectorTM Y Unit
    Enables the direct Nucleofection of cells in adherence in 24-well culture plates
    Catalog #: AAF-1002Y
    Sales unit: items
    Compare
    ST
  • 4D-Nucleofector<sup>TM</sup> Core Unit
    4D-NucleofectorTM Core Unit
    The controlling unit of the 4D-NucleofectorTM System is suited to handle various fuctional units for efficient transfection of hard-to-transfect cell lines and primary cells in different formats.
    Catalog #: AAF-1002B
    Sales unit: items
    Compare
    ST
  • 384-well Nucleofector<sup>TM</sup> System
    384-well NucleofectorTM System
    An independent NucleofectorTM Platform for high-throughput transfection in 384-well format
    Catalog #: AAU-1001
    Sales unit: items
    Compare
    ST
  • Nucleofector<sup>TM</sup> 2b Device
    NucleofectorTM 2b Device
    The basic, single cuvette based NucleofectorTM System for efficient transfection of hard-to-transfect cell lines and primary cells with different substrates (e.g., DNA vectors or siRNA oligonucleotides) in low-throughput format
    Catalog #: AAB-1001
    Sales unit: items
    Compare
    ST
  • 4D-Nucleofector<sup>TM</sup> LV Unit
    4D-NucleofectorTM LV Unit

    For closed, scalable large-scale transfection of up to 1x109 cells

    Catalog #: AAF-1002L
    Sales unit: items
    Compare
    ST
  • 4D-Nucleofector<sup>TM</sup> X Unit
    4D-NucleofectorTM X Unit

    Supports Nucleofection of various cell numbers in 100 µL cuvettes or 20 µL 16-well strips

    Catalog #: AAF-1002X
    Sales unit: items
    Compare
    ST
  • 96-well Shuttle<sup>TM</sup> Device
    96-well ShuttleTM Device

    The medium-throughput add-on for the 4D-NucleofectorTM System suited for transfection of hard-to-transfect cell lines or primary cells in 96-well plates

    Catalog #: AAM-1001S
    Sales unit: items
    Compare
    ST
  • We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok